Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CACNA1B | Q00975 | 2/20 | 0.37 |
| ▸ | AOC3 | Q16853 | 2/20 | 0.36 |
| ▸ | HTT | P42858 | 1/20 | 0.36 |
| ▸ | IDO1 | P14902 | 2/20 | 0.35 |
| ▸ | TDO2 | P48775 | 2/20 | 0.35 |
| ▸ | CTSL | P07711 | 2/20 | 0.35 |
| ▸ | NOS3 | P29474 | 1/20 | 0.35 |
| ▸ | NOS1 | P29475 | 1/20 | 0.35 |
| ▸ | NOS2 | P35228 | 1/20 | 0.35 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.34 |
| ▸ | MAOA | P21397 | 1/20 | 0.34 |
| ▸ | MAOB | P27338 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL56346 | 0.77 | TAAR1 (0.43) | AOC3TRPA1 | |
| SCHEMBL9880972 | 0.77 | CACNA1B (0.39) | CACNA1BAOC3HTTIDO1TDO2 | |
| SCHEMBL16232202 | 0.77 | CACNA1B (0.39) | CACNA1BAOC3HTTIDO1TDO2 | |
| SCHEMBL8017502 | 0.77 | AOC3 (0.38) | AOC3HTTIDO1TDO2 | |
| SCHEMBL6100251 | 0.77 | CACNA1B (0.45) | CACNA1BAOC3HTTIDO1TDO2 | |
| SCHEMBL21503471 | 0.77 | CACNA1B (0.39) | CACNA1BAOC3HTTIDO1TDO2 | |
| SCHEMBL13995158 | 0.74 | MAOA (0.42) | CACNA1BAOC3HTTIDO1TDO2 | |
| SCHEMBL16673700 | 0.74 | AOC3 (0.53) | CACNA1BAOC3HTTCTSLTRPA1 | |
| SCHEMBL14737295 | 0.74 | IDO1 (0.42) | AOC3HTTIDO1TDO2MAOA | |
| SCHEMBL1005314 | 0.74 | IDO1 (0.42) | AOC3HTTIDO1TDO2MAOA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100069244-A1 | Pyridine Compounds for Combating Pests | BASF SE (DE) | 2010-03-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100069244-A1 | Pyridine Compounds for Combating Pests | CHRM1, PRDX1, CHRM2 | CACNA1B 1314/4885AOC3 660/4885HTT 3328/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.